Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1972 Nov 11;4(5836):360. doi: 10.1136/bmj.4.5836.360-a

Respiratory distress syndrome.

E L Lloyd
PMCID: PMC1786586  PMID: 4564858

Full text

PDF

Page 360

360

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bhagwanani S. G., Fahmy D., Turnbull A. C. Prediction of neonatal respiratory distress by estimation of amniotic-fluid lecithin. Lancet. 1972 Jan 22;1(7743):159–162. doi: 10.1016/s0140-6736(72)90566-1. [DOI] [PubMed] [Google Scholar]
  2. Boughton K., Gandy G., Gairdner D. Hyaline membrane disease. II. Lung lecithin. Arch Dis Child. 1970 Jun;45(241):311–320. doi: 10.1136/adc.45.241.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gregory G. A., Kitterman J. A., Phibbs R. H., Tooley W. H., Hamilton W. K. Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure. N Engl J Med. 1971 Jun 17;284(24):1333–1340. doi: 10.1056/NEJM197106172842401. [DOI] [PubMed] [Google Scholar]
  4. JAMIESON D., VANDENBRENK H. A. THE EFFECTS OF ANTIOXIDANTS ON HIGH PRESSURE OXYGEN TOXICITY. Biochem Pharmacol. 1964 Feb;13:159–164. doi: 10.1016/0006-2952(64)90133-9. [DOI] [PubMed] [Google Scholar]
  5. Reynolds E. O., Roberton N. R., Wigglesworth J. S. Hyaline membrane disease, respiratory distress, and surfactant deficiency. Pediatrics. 1968 Nov;42(5):758–768. [PubMed] [Google Scholar]
  6. Shanklin D. R., Cunningham J. J., Sotelo-Avila C., Crussi F. Oxygen, ascorbic acid, and the lung. Participation of adrenal ascorbic acid in response to oxygen challenge of the lung. Arch Pathol. 1967 Nov;84(5):451–459. [PubMed] [Google Scholar]
  7. Shanklin D. R., Lester E. P. On the pulmonary toxicity of oxygen. II. The effect of the second gas. Biol Neonate. 1972;20(1):140–158. doi: 10.1159/000240457. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES